Remote Monitored Systems plc share price, company news, analysis and interviews

Remote Monitored Systems plc (LON:RMS) has acknowledged the press release announced today by the British High Commission regarding its Anglo-Indian partnership to distribute its MHRA approved Pro-Larva mask in India: The British High Commission is delighted to announce a new Anglo-Indian partnership between British technology firm Pharm 2 Farm Limited, a subsidiary of nanosynth group plc, and India’s VKE Enterprises to distribute British MHRA approved Pro-Larva mask which is proven to kill Covid-19 and Influenza viruses, using unique patented nano-technology developed at Nottingham Trent University. This important healthcare partnership introduces affordable technology that will help protect the Indian population, saving lives and supporting

Remote Monitored Systems plc (LON:RMS) has announced an AGM statement. Antony Legge, Executive Chairman of RMS, will make the following statement at today’s annual general meeting: “Since 1 July 2020, just over one year ago, the Company’s shareholder base has more than tripled in size through the issues of shares to investors either directly or indirectly connected with or interested in Pharm 2 Farm Ltd.  Initially, investors were excited with Pham 2 Farm’s ability to embed copper nanoparticles in such a way as to make anti-viral masks.  During the COVID-19 pandemic, this was seen as a potential game changer.  However, one cannot build

Notice of AGM and GM Remote Monitored Systems plc (LON:RMS) has announced that, further to the announcement on 17 June 2021, it has posted to shareholders the notices of the 2021 AGM and GM which will both be held on 17 August 2021 at the Crowne Plaza Hotel, Wollaton St, Nottingham NG1 5RH. The 2021 AGM will be held at 11.30 a.m. with the GM immediately beforehand at 11.00 a.m. As announced on 9 June 2021, the Company has called the GM to consider the transfer of its shares in Gyrometric Systems Ltd. Special business for shareholders to consider at the AGM

Remote Monitored Systems plc (LON:RMS) has announced that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd, has been approved by the UK’s Medicines and Healthcare products Regulatory Agency (“MHRA”).  The 5-ply mask has an additional filter layer, produced by Volz, after the hydrophobic outer layer, further strengthening the mask’s already excellent bacterial filter efficiency. The last year has established a close working relationship between Volz and the Company’s subsidiary, Pharm 2 Farm Ltd (“P2F”).  Not only is Volz manufacturing the existing 4-ply anti-viral masks for P2F, but the two companies have also been working on developing